NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Advanced Bifurcation Systems (ABS), a clinical-stage medical device company with a patented bifurcation stenting platform to standardize the treatment of all ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Advanced Bifurcation Systems announced ...

January 20, 2009 (Washington, DC) — A new, self-expanding, drug-eluting stent with a flared configuration has proved itself to be safe and effective in bifurcated lesions, at least out to nine months, ...

PARIS, France—A novel, biodegradable-polymer, sirolimus-eluting stent designed to treat bifurcation lesions demonstrates positive angiographic and clinical results in a first-in-man registry ...

For patients with bifurcation lesions, the new dual-stent modified “flower petal” technique offers several advantages over available stenting options, including complete coverage of the side branch ...

Bifurcation lesions continue to be a source of frustration for the interventional cardiologist. Despite a series of innovative techniques and even more inventive names, the procedure can be prolonged ...

Bifurcation lesions are a challenge, even for an experienced cardiac surgeon. Currently, there are two surgical techniques for dealing with them, but no medical consensus on which one applies to which ...

The preference for provisional stenting over dedicated stents for bifurcation coronary lesions still stands, but with further development, dedicated bifurcation stents could still become a viable ...

DENVER – When stenting unprotected left main bifurcation lesions, a double kissing (DK) crush technique yields better outcomes than the typical provisional approach, the DKCRUSH-V trial showed. For ...

LIVERMORE, Calif., Dec. 16, 2020 /PRNewswire/ -- Advanced Bifurcation Systems, Inc. (ABS), a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically ...